Summary
A stability-indicating high-performance liquid chromatographic method has been used to investigate the stability of chlorambucil in solution. Dissolved in ethanol and diluted with 150 mM NaCl (NS), the drug was found to be very much more stable frozen, with a value for 5% degraded (t 0.95 ) of approximately 8 months at-70°C. The presence of agar of cells, and freezing and thawing the solution did not reduce the concentration of chlorambucil significantly. The drug seemed to adsorb to polyvinyl chloride (PVC) infusion bags (but to no other container material) and also to all three filtration units tested. Intense light increased the degradation of the drug, whilst the addition of 10% serum to chlorambucil in medium increased the drug's stability four fold. Dilution with NS of stock solutions of chlorambucil in ethanol resulted in supersaturated solutions of the drug.
For preparation of the drug for in vitro drug sensitivity assays, the results suggest that care should be taken (a) in the initial dilution of the drug; (b) not to use filtration units to sterilize solutions; (c) to anticipate different degradation rates (and therefore cytotoxicity) if the serum concentration in medium is altered; and (d) to avoid the use of PVC.
Similar content being viewed by others
References
Bird MC, Bosanquet AG, Gilby ED (1985) In vitro determination of tumour chemosensitivity in haematological malignancies. Hematol Oncol 3: 1–10
Bird MC, Bosanquet AG, Forskitt S, Gilby ED (1986) Semimicro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in vitro chemosensitivity of haematological malignancies. Leuk Res 10: 445–449
Bosanquet AG (1985a) Stability of melphalan solutions during preparation and storage. J Pharm Sci 74: 348–351
Bosanquet AG (1985b) Stability of solutions of anti-neoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents. Cancer Chemother Pharmacol 14: 83–95
Bosanquet AG (1986) Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays: II. Assay methods, adriamycin and the other antitumour antibiotics. Cancer Chemother Pharmacol 17: 1–10
Bosanquet AG, Gilby ED (1982) Measurement of plasma melphalan at therapeutic concentrations using isocratic highperformance liquid chromatography. J Chromatogr 232: 345–354
Bosanquet AG, Bird MC, Price WJP, Gilby ED (1983) An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia. Br J Cancer 47: 781–789
Chatterji DC, Yeager RL, Galleli JF (1982) Kinetics of chlorambucil hydrolysis using high-pressure liquid chromatography. J Pharm Sci 71: 50–54
Ehrsson H, Eksborg S, Wallin I, Nilsson SO (1980) Degradation of chlorambucil in aqueous solution. J Pharm Sci 69: 1091–1094
Ehrsson H, Lonroth U, Wallin I, Ehrnebo M, Nilsson SO (1981) Degradation of chlorambucil in aqueous solution-influence of human albumin binding. J Pharm Pharmacol 33: 313–315
King S-YP, Kung M-S, Fung H-L (1984) Statistical prediction of drug stability based on nonlinear parameter estimation. J Pharm Sci 73: 657–662
Owen WR, Stewart PJ (1979) Kinetics and mechanism of chlorambucil hydrolysis. J Pharm Sci 68: 992–996
Schiffman JF, Fisher JM, Rabinovitz M (1977) Serum displacing agents in cancer chemotherapy. Cancer Treat Rep 61: 1407–1410
Von Hoff DD, Casper J, Bradley E, Sandbach J, Jones D, Makuch R (1981) Association between human tumor colonyforming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 70: 1027–1032
Author information
Authors and Affiliations
Additional information
The work described in this paper was generously supported by the Leukaemia Research Fund and the Bath Area Medical Research Trust
Rights and permissions
About this article
Cite this article
Bosanquet, A.G., Clarke, H.E. Chlorambucil: stability of solutions during preparation and storage. Cancer Chemother. Pharmacol. 18, 176–179 (1986). https://doi.org/10.1007/BF00262292
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00262292